JP Morgan Chase
BCAB icon

JP Morgan Chase’s BioAtla BCAB Stock Holding History

JP Morgan Chase’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20 Hold
3
– – ﹤0.01% 7408
2025
Q4 		$73 Sell
3
-20
-87% -$784 ﹤0.01% 7236
2025
Q3 		$777 Hold
23
– – ﹤0.01% 7011
2025
Q2 		$447 Sell
23
-3
-12% -$61 ﹤0.01% 6707
2025
Q1 		$443 Buy
26
+3
+13% +$64 ﹤0.01% 6716
2024
Q4 		$667 Hold
23
– – ﹤0.01% 6773
2024
Q3 		$1.99K Sell
23
-144
-86% -$12.1K ﹤0.01% 6623
2024
Q2 		$11.4K Sell
167
-444
-73% -$52.8K ﹤0.01% 6233
2024
Q1 		$105K Sell
611
-169
-22% -$21K ﹤0.01% 5650
2023
Q4 		$95.9K Sell
780
-131
-14% -$11.4K ﹤0.01% 5750
2023
Q3 		$77.4K Buy
911
+4
+0.4% +$510 ﹤0.01% 5630
2023
Q2 		$136K Buy
907
+706
+351% +$121K ﹤0.01% 5307
2023
Q1 		$27K Sell
201
-3,115
-94% -$561K ﹤0.01% 5896
2022
Q4 		$1.37M Sell
3,316
-2,248
-40% -$933K ﹤0.01% 3848
2022
Q3 		$2.14M Buy
5,564
+67
+1% +$21.9K ﹤0.01% 3408
2022
Q2 		$783K Buy
5,497
+5,172
+1,591% +$823K ﹤0.01% 4263
2022
Q1 		$81K Buy
325
+25
+8% +$10.5K ﹤0.01% 5600
2021
Q4 		$295K Sell
300
-230
-43% -$294K ﹤0.01% 5141
2021
Q3 		$780K Buy
530
+362
+215% +$705K ﹤0.01% 4474
2021
Q2 		$356K Sell
168
-1,434
-90% -$3.24M ﹤0.01% 4911
2021
Q1 		$4.07M Buy
1,602
+1,580
+7,182% +$4.05M ﹤0.01% 3147
2020
Q4 		$37K Buy
+22
New +$36.8K ﹤0.01% 5214

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's BCAB Position: Q1 2026 in Review

JP Morgan Chase held its BioAtla (BCAB) position steady in Q1 2026 at 3 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #7408.

JP Morgan Chase first reported a position in BCAB in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.07M in Q1 2021. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

  • JP Morgan Chase held 3 shares of BioAtla worth $20 as of Q1 2026.
  • JP Morgan Chase left its BioAtla share count unchanged in Q1 2026.
  • BioAtla made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7408 holding.
  • JP Morgan Chase first reported a position in BioAtla in Q4 2020 and has held it in 22 quarters since.
  • JP Morgan Chase's BioAtla position peaked at $4.07M in Q1 2021.
  • 36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.